Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity
通过GSTM1基因分型优化拉泽替尼治疗:一种减少药物过量暴露和潜在毒性的策略
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-025-04828-y
Ter Heine, Rob; van den Bosch, Bianca J C; van Geel, Robin M; van Geffen, Wouter H; Hendriks, Lizza E L; van den Heuvel, Michel M; Koele, Simon E; de Langen, Adrianus J; Oude Munnink, Thijs H; van der Wekken, Anthonie J